| |
| |
|
| Insider
Information: |
Cook Meredith |
| Relationship: |
SR. VP, GENERAL COUNSE... |
| City: |
Baudette |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
59,731 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,973,306 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
59,731 |
|
|
| Total
Value |
$3,973,306 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ANI Pharmaceuticals Inc |
ANIP |
SR. VP, GENERAL COUNSE... |
2024-04-12 |
59,731 |
2022-07-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2024-04-12 |
4 |
AS |
$67.79 |
$16,948 |
D/D |
(250) |
59,731 |
0 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2024-03-13 |
4 |
AS |
$66.54 |
$16,635 |
D/D |
(250) |
59,981 |
0 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2024-02-29 |
4 |
D |
$67.67 |
$79,377 |
D/D |
(1,173) |
60,231 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
24,605 |
61,404 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2024-02-13 |
4 |
AS |
$56.04 |
$14,010 |
D/D |
(250) |
36,799 |
0 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2024-01-12 |
4 |
AS |
$56.43 |
$14,108 |
D/D |
(250) |
37,049 |
0 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2023-12-11 |
4 |
AS |
$49.21 |
$12,303 |
D/D |
(250) |
37,299 |
0 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2023-11-13 |
4 |
AS |
$52.03 |
$13,008 |
D/D |
(250) |
37,549 |
0 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2023-07-18 |
4 |
D |
$51.89 |
$90,444 |
D/D |
(1,743) |
37,799 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SR. VP, GENERAL COUNSEL & SEC. |
• – – |
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
19,280 |
19,280 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
